Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Incyte

EMA starts review of MorphoSys’ tafasitamab for lymphoma

EMA starts review of MorphoSys’ tafasitamab for lymphoma

Incyte bought into the programme in January, paying a sizeable $750m upfront for rights to the drug as well as making a $150m equity investment in MorphoSys. ... In the US the two countries will share eco-promotion rights and profits, while Incyte has

Incyte launches award programme recognising innovation in GVHD community

Incyte launches award programme recognising innovation in GVHD community have a devastating impact on the lives of patients,” said Barry Flannelly, executive vice president and general manager, US, Incyte. ... Through the Incyte Ingenuity Award, we hope to spark creativity and innovation, which we expect to result in

Incyte’s JAK inhibitor cream clears second eczema trial

Incyte’s JAK inhibitor cream clears second eczema trial Set for regulatory filings later this year. Incyte now has a pair of positive phase 3 trials for its topical formulation of JAK1/2 inhibitor ruxolitinib in atopic dermatitis or eczema, ... Incyte has said it intends to market ruxolitinib cream itself in

Novartis pulls ahead of Merck in MET-positive lung cancer race

Novartis pulls ahead of Merck in MET-positive lung cancer race Capmatinib – originally developed by Incyte and licensed to Novartis in 2009 – has been submitted for approval in the US for metastatic MET exon14 skipping-mutated NSCLC, a form of lung cancer

Incyte signs lymphoma deal worth up to $1.1bn with MorphoSys

Incyte signs lymphoma deal worth up to $1.1bn with MorphoSys to patients and the clinical community around the world,” said Hervé Hoppenot, CEO of Incyte. ... Under the terms of the deal, Incyte is paying MorphoSys $750m upfront, as well as making an equity investment worth $150m in the company.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency. We dispense pioneering and creative campaigns, driven by...

Latest intelligence

AI and genomics: a revolution in drug discovery and development
...
Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....

Infographics